Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14520: Variant p.Gly534Glu

Hyaluronan-binding protein 2
Gene: HABP2
Feedback?
Variant information Variant position: help 534 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Glutamate (E) at position 534 (G534E, p.Gly534Glu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to medium size and acidic (E) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In NMTC5; associated with disease susceptibility; variant Marburg I; could be a prominent risk predictor of carotid stenosis; impairs the pro-urokinase activating potency; increased cell migration and increased cell proliferation; dominant negative effect. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 534 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 560 The length of the canonical sequence.
Location on the sequence: help TCEKDGTYYVYGIVSWGLEC G KRPGVYTQVTKFLNWIKATI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         TCEKDGTYYVYGIVSWGLECGKRPGVYTQVTKFLNWIKATI

Mouse                         TCEKDGTYYVYGIVSWGQECGKKPGVYTQVTKFLNWIKTTM

Rat                           TCEKDGTYYVYGIVSWGQECGKKPGVYTQVTKFLNWIKTTM

Bovine                        TCEKDGTSYIYGIVSWGLECGKRPGVYTQVTKFLTWIKATM
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 314 – 560 Hyaluronan-binding protein 2 27 kDa light chain
Chain 320 – 560 Hyaluronan-binding protein 2 27 kDa light chain alternate form
Domain 314 – 555 Peptidase S1



Literature citations
Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ILE-90 AND GLN-393; VARIANT NMTC5 GLU-534; Marburg I polymorphism of factor VII-activating protease: a prominent risk predictor of carotid stenosis.
Willeit J.; Kiechl S.; Weimer T.; Mair A.; Santer P.; Wiedermann C.J.; Roemisch J.;
Circulation 107:667-670(2003)
Cited for: VARIANT GLN-393; VARIANT NMTC5 GLU-534; Germline HABP2 mutation causing familial nonmedullary thyroid cancer.
Gara S.K.; Jia L.; Merino M.J.; Agarwal S.K.; Zhang L.; Cam M.; Patel D.; Kebebew E.;
N. Engl. J. Med. 373:448-455(2015)
Cited for: FUNCTION; INVOLVEMENT IN NMTC5; VARIANT NMTC5 GLU-534; CHARACTERIZATION OF VARIANT NMTC5 GLU-534;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.